Leveraging Epigenetic Biomarkers and CRISPR-Cas12a for Early Prostate Cancer Detection in Sub-Saharan Africa: Opportunities and Challenges

dc.contributor.authorNguedia,Niels K.
dc.contributor.authorAmadi, Emmanuel C.
dc.contributor.authorKintung, lrrinus F.
dc.contributor.authorOgunlana, Olubanke 0.
dc.contributor.authorChinedu, Shalom N
dc.date.accessioned2026-02-19T11:08:25Z
dc.date.issued2026
dc.identifier.issndoi: 10.20944/preprints202507.09B4.v1
dc.identifier.urihttps://repository.covenantuniversity.edu.ng/handle/123456789/50627
dc.language.isoen
dc.publisherPreprints
dc.subjectepigenetic signatures
dc.subjectCRISPR-Cas12a
dc.subjectprostate cancer
dc.subjectearly detection
dc.subjectliquid biopsy
dc.subjectSub Saharan Africa
dc.titleLeveraging Epigenetic Biomarkers and CRISPR-Cas12a for Early Prostate Cancer Detection in Sub-Saharan Africa: Opportunities and Challenges
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
download_pub.pdf
Size:
2.38 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: